(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 24.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Seer's revenue in 2026 is $15,166,000.On average, 4 Wall Street analysts forecast SEER's revenue for 2026 to be $911,319,208, with the lowest SEER revenue forecast at $872,887,104, and the highest SEER revenue forecast at $941,009,245. On average, 4 Wall Street analysts forecast SEER's revenue for 2027 to be $1,174,900,763, with the lowest SEER revenue forecast at $1,104,579,360, and the highest SEER revenue forecast at $1,235,435,451.
In 2028, SEER is forecast to generate $1,592,705,569 in revenue, with the lowest revenue forecast at $1,497,917,375 and the highest revenue forecast at $1,674,188,228.